AR and prostate carcinoma: These two candidates, LHJ-647 and HWC-489, additionally suppressed prostate cancer cell xenografts harboring endogenous AR and growth in a NOD/SCID mouse model with statistical significance, based on comparisons of tumor volume (Figure 5B), tumor weight (Figure 5C).